IFNG and hepatocellular carcinoma: Silencing PKM2 inhibits HCC proliferation, migration, and invasion whereas overexpression of PKM2 increases interferon gamma (IFNγ)-positive CD8+ T cells in the HCC mouse model by activating an immune checkpoint blockade (94).